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TO THE EDITOR:
Syndromic craniosynostosis is associated with various manifesta-
tions primarily involving osseous defects and neurological im-
pairment. Up to 180 distinct syndromes have been associated
with craniosynostosis and the identification of underlying genetic
defects is continually improving [Kimonis et al., 2007]. Mutations
in genes of the FGFR family are most common and account for
various clinical conditions [Arlt, 2007; Wilkie et al., 2007], while
other well-characterized mutations involving TWIST1 [El Ghouzzi
et al., 1997], RAB23 [Jenkins et al., 2007], EFNB1 [Wieland et al.,
2004], or MSX2 genes [Jabs et al., 1993] have been described. In
these cases, one single gene mutation can generate various clinical
phenotypes, or inversely, a single phenotype (e.g., craniosynostosis)
can correspond to several gene mutations. Additionally, a large
number of chromosomal deletions or duplications have been
related to syndromic craniosynostosis, including del(7p) [Chotai
et al., 1994], del(9p) [Alfi et al., 1976], del(11q) [Lewanda et al.,
1995], del(15q) [Hiraki et al., 2008], and dup(5q) [Breslau-Siderius
et al., 1993]. However, the clinical significance of these large
chromosomal aberrations is often difficult to extrapolate due to
variability in the size of the genetic region involved and in the
corresponding clinical presentation. Here, we describe for the first
time an interstitial 19p13.2–p13.13 deletion associated with com-
plex craniosynostosis, developmental delay, and malformations.
The present case is the fourth child of unrelated healthy parents
and the only affected child. Family history is unremarkable except for
one miscarriage and one vanishing twin during propositus’ preg-
nancy. The antenatal period was characterized by a third trimester
ultrasound showing nuchal translucency at 80th centile and intra-
uterine growth retardation associated with umbilical arterial throm-
bosis. Ultrasound was otherwise normal. The patient was delivered
by cesarean at 36 weeks 6/7, weighing 1,800 g and measuring 43 cm
(both below2 SD); the head circumference was 30.5 cm (2 SD).
She was admitted to the neonatal care center for respiratory distress.
Clinical examination revealed general hypotonia and anomalies,
including hypoplasia of the left orbit and a prominent frontal bone
bulge (Fig. 1IA), hypertelorism, proptosis, strabismus, small nose
with low nasal bridge, low set ears with underfolded superior helix
(Fig. 1IB–D), deep skin folds on the hands and feet, arthrogryposis of
the lower limbs, and clinodactyly of the fifth finger and third toe
(Fig. 1IE,F) with an increased space between the first and second toe.
Chest examination revealed a systolic murmur and an atrial septal
defect was diagnosed by echocardiogram. Cerebral three-dimen-
sional computed tomography scan showed a complex craniosynos-
tosis with fusion of the left coronal, lambdoid, and parieto-temporal
sutures together with left spheno-orbital dysplasia (Fig. 1II). Mod-
erate ventriculomegaly was noted on cerebral magnetic resonance
imaging. Retinal inspection was normal but neurophysiological
examination revealed a hearing threshold of 60 dB in both ears,
while electroencephalography showed a too large proportion of slow
elements. At 4 months, facial asymmetry increased with deformation
of the left hemi-mandible and orbit. The patient’s psycho-motor
development was delayed at 6 months with a lack of visual contact,
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FIG. 1. Photographs and skull imaging of the patient. I: Appearance of the face (A, frontal view) and the right ear horn (B) of the propositus at birth.
Aspect of the head (C, frontal view; D, right profile) and of the right hand (E, dorsal face) at 1 year old. Medial side of left foot at 3 years old (F). II:
Cerebral three-dimensional computed tomography scan showing skull deformation on the left side with left orbitary hypoplasia and left posterior
plagiocephaly. Craniosynostosis was remarked at the level of left coronal, parieto-temporal and lambdoid sutures. Partial craniosynostosis could
also be identified at the level of left spheno-squamous and spheno-frontal sutures. Digitiform imprints were noticed in the left parieto-temporal
region. Pictures show front (A), back (B), left (C), and right (D) views of the skull.
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FIG. 2. Interstitial deletion from 19p13.2 to 19p13.13 detected by aCGH and FISH. A: Representation of normalized aCGH data for the whole
chromosome 19 (I). Only probes with a copy number ratio 0.5 are represented by green dots (negative copy number ratio) or red dots (positive
copy number ratio). Positive regions were considered only with more than three consecutive abnormal dots. The moving average (purple line) based
on the Cy3:Cy5 ratio of fluorescence intensity of each probe shows a leftward deviation from the central axis at 19p13.2–p13.13 bands, revealing the
interstitial deletion. Identical representation with enlargement of the deleted segment (II). B: FISH analysis of the 19p13.13–p13.2 deletion.
Spectrum-green labeled BAC clones RP11-91O21 (I) and RP11-19I2 (II), mapped on 19p13.2, were hybridized with a spectrum-orange labeled T19q
subtelomeric probe used for identification of chromosomes 19. Arrow points to the green signal on normal chromosome 19 and arrowhead indicates
the absence of green signal on chromosome del(19)(p13.13p13.2), confirming aCGH results.
2566 AMERICAN JOURNAL OF MEDICAL GENETICS PART A
and weight and head circumference remaining at 2 SD. Further-
more, she had a considerable degree of kyphosis. At 1 year, she
underwent surgery for correction of the craniosynostosis by opening
of the prematurely fused sutures. Following surgery, the craniofacial
manifestations improved rapidly but neurological skills did not
evolve similarly. The patient was able to sit at the age of 15 months
and stood with help at 33 months. Currently, at 3 years and 8 months
of age, the patient still has no language acquisition. She weighs
12.3 kg (3.4 SD), is 104 cm in height (0.9 SD) and has a head
circumference of 49 cm (0.7 SD).
Neurofibromatosis type 1 was excluded by absence of the NF1
gene mutation. Testing was negative for TWIST1 and FGFR3
craniosynostosis gene mutations. Testing for a TWIST-1 gene
defect by MLPA was negative and no mutation (P250R) in exon
7 of the FGFR3 gene was detected. The presence of a constitutional
chromosomal abnormality was investigated by conventional G-
banding karyotype but was apparently normal (46 XX; 550-band
resolution). We then performed an array comparative genomic
hybridization (aCGH) analysis on Agilent 44K-array following the
manufacturer’s instructions and the data were analyzed with their
Feature Extraction 9.1 software. Data were then processed with the
Agilent CGH Analytics 3.4 software using the z-score statistical
algorithm (sensitivity threshold set at 2.5 and moving average
window at 2.0 Mb). A 3-Mbp interstitial deletion was detected on
chromosomal bands 19p13.2–19p13.13 (NCBI Build 36.1), with
the distal breakpoint between chr19:10,246,651 and 10,256,871 bp
and the proximal breakpoint between chr19:13,188,698 and
13,280,203 bp (Fig. 2A). The deleted sequences were carefully
analyzed for segmental duplications using the website from Tor-
onto University (http://projects.tcag.ca), which found no evidence
that this region is located within duplicons that allow recombina-
tion (duplication/deletion) events. This chromosomal region con-
tains 114 genes/ESTs between the ICAM1 and CACNA1A genes.
To validate this observation, fluorescent in situ hybridization
(FISH) analysis was carried out using 19p13.2-mapped BAC
probes following standard labeling and hybridization protocols.
The fluorescent signal of BACs was absent on one of the two
chromosomes 19, confirming the deletion (Fig. 2B). Karyotyping
and FISH analysis were performed on peripheral blood mono-
nuclear cells (PBMCs) from the parents, brother and sisters of the
propositus and no 19p13.2 rearrangement was found (data not
shown), indicating de novo acquisition of the 19p13.2–p13.13
deletion in our patient.
Partial chromosome 19 deletions are extremely rare. Terminal
19p13-pter deletion has been described in a 16-year-old male,
associated with dysmorphism, congenital heart malformation,
epilepsy, conductive deafness, and global learning difficulties
[Archer et al., 2005], and in a 2-month-old boy with microcephaly,
deafness, retinal scars, and dysmorphism [Hurgoiu and Suciu,
1984]. In the Sanger online repository of chromosomal imbalances
(https://decipher.sanger.ac.uk/), two cases with 19p13.2 deletion
are described with mental and developmental retardation without
craniosynostosis (patient numbers 00001857 and 00000757). These
aberrations overlap the distal part of the deleted region observed in
our propositus, suggesting the presence of a gene whose hemizy-
gous status can predispose to craniosynostosis in the proximal part
of the deletion (chr19:12,063,888–13,188,698 bp). Recently, two
reports of 19p constitutional deletions have been published [Aten
et al., 2009; Jensen et al., 2009]. However, the deleted regions
described in these studies (deletion 19p13.12 and l9p13.3pter,
respectively) do not overlap the chromosomal region of our patient.
Furthermore, the patients in these studies present common traits
with two other cases reported without craniosynostosis [Hurgoiu
and Suciu, 1984; Archer et al., 2005].
The chromosomal segment detected in our patient contains the
DAND5 and CALR genes, both involved in the metabolism of bone
morphogenesis or osteoblastic cells, suggesting that one or both are
potentially involved in the craniosynostosis. In particular, the
DAND5 gene encodes a member of the BMP (bone morphogenic
protein) antagonist family and has been shown to regulate tissue
differentiation [Avsian-Kretchmer and Hsueh, 2004; Marques
et al., 2004]. The CALR (calreticulin) gene encodes a chaperone
protein mediating the attenuating effect of glucocorticoids in Wnt
signaling in osteoblastic cells, thereby plays an important role in
controlling osteoblastogenesis [Oikku and Mahonen, 2009]. How-
ever, because our case represents a currently isolated report of copy
number variation in the 19p13.2p13.1 region associated with
craniosynostosis, it is possible that this phenotype occurred by
chance or is due to a multi-gene effect associated with several of the
numerous genes included in the deletion. Moreover, the lack of
craniosynostosis in two other patients carrying the commonly
deleted region might also be due to lower penetrance of the same
hemizygote gene.
In the syndromic forms of craniosynostosis, gene mutations
account for 25% of cases [Wilkie et al., 2007] and, using kar-
yotyping and molecular genetic techniques, causative chromosom-
al imbalances have recently been detected in 19/45 patients (42%)
[Jehee et al., 2008]. These results indicate that genetic anomalies
represent a critical etiology in this particular phenotype. To our
knowledge, craniosynostosis has never been reported in association
with chromosome 19 imbalances. However, the lack of distinguish-
able bands on this chromosome may have prevented the detection
of aberrations in previous karyotyping studies. Using aCGH, we
were able to show an interstitial 19p13.2–p13.13 deletion for the
first time associated with syndromic craniosynostosis, pointing to
an important new craniosynostosis locus.
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